Table 4 Levels of NLPR and MLPR and risk stratification for AKI
| Â | n | AKI | Severe AKI | ||||
|---|---|---|---|---|---|---|---|
n (%) | aOR (95% CI) | P | n (%) | aOR (95% CI) | P | ||
MLPR | |||||||
 0–1.9 | 177 | 8 (4.5) | Ref. | – | 1 (0.6) | Ref. | – |
 2.0–3.9 | 218 | 24 (11.0) | 2.02 (0.90–5.01) | 0.105 | 4 (1.8) | 2.56 (0.37–50.83) | 0.406 |
 4.0–7.9 | 220 | 31 (14.1) | 2.27 (1.03–5.52) | 0.050 | 9 (4.1) | 5.20 (0.94–97.17) | 0.123 |
 8.0–15.9 | 146 | 34 (23.3) | 4.91 (2.23–12.01) |  < 0.001 | 15 (10.3) | 18.75 (3.62–344.76) | 0.005 |
 16.0–31.9 | 77 | 23 (29.9) | 6.11 (2.56–15.92) |  < 0.001 | 10 (13.0) | 22.59 (3.95–428.02) | 0.004 |
  ≥ 32.0 | 103 | 57 (55.3) | 24.38 (11.10–60.10) |  < 0.001 | 46 (44.7) | 161.40 (32.72–2931.98) |  < 0.001 |
NLPR | |||||||
 0–1.9 | 196 | 7 (3.6) | Ref. | – | 1 (0.5) | Ref. | – |
 2.0–3.9 | 233 | 29 (12.4) | 3.02 (1.34–7.79) | 0.012 | 6 (2.6) | 4.09 (0.67–78.51) | 0.198 |
 4.0–7.9 | 182 | 30 (16.5) | 3.83 (1.68–9.88) | 0.003 | 9 (4.9) | 8.41 (1.50–157.74) | 0.047 |
 8.0–15.9 | 126 | 23 (18.3) | 5.18 (2.20–13.69) |  < 0.001 | 9 (7.1) | 14.74 (2.63–277.24) | 0.012 |
 16.0–31.9 | 73 | 21 (28.8) | 8.35 (3.38–22.89) |  < 0.001 | 6 (8.2) | 17.81 (2.81–347.38) | 0.010 |
  ≥ 32.0 | 131 | 67 (51.1) | 26.59 (12.01–67.90) |  < 0.001 | 54 (41.2) | 160.06 (32.64–2906.32) |  < 0.001 |